Medical Research for Hire The Political Economy of Pharmaceutical Clinical Trials

Today, more than 75 percent of pharmaceutical drug trials in the United States are being conducted in the private sector. Once the sole province of academic researchers, these important studies are now being outsourced to non-academic physicians. According to Jill A. Fisher, this major change in the...

Full description

Saved in:
Bibliographic Details
Main Author Fisher, Jill A
Format eBook Book
LanguageEnglish
Published United States Rutgers University Press 2008
Rutgers Univ. Press
Edition1
SeriesCritical Issues in Health and Medicine
Subjects
Clinical trials
Clinical trials > Economic aspects > United States
Clinical trials > Moral and ethical aspects > United States
Clinical Trials as Topic
Clinical Trials as Topic > ethics
Contracting out
Contracting out > United States
Drug Industry
Drug Industry > ethics
Drugs
Drugs > Testing > Economic aspects > United States
Drugs > Testing > Moral and ethical aspects > United States
Economic aspects
ethics
Ethik
Health Sciences
MEDICAL
MEDICAL / General
Medical sciences
Moral and ethical aspects
Outsourcing
Pharmakologie
Privatwirtschaft
Public Health
Research Subjects
Testing
United States
USA
United States
Online AccessGet full text

Cover

More Information
Summary:Today, more than 75 percent of pharmaceutical drug trials in the United States are being conducted in the private sector. Once the sole province of academic researchers, these important studies are now being outsourced to non-academic physicians. According to Jill A. Fisher, this major change in the way medical research is performed is the outcome of two problems in U.S. health care: decreasing revenue for physicians and decreasing access to treatment for patients. As physicians report diminishing income due to restrictive relationships with insurers, increasing malpractice insurance premiums, and inflated overhead costs to operate private practices, they are attracted to pharmaceutical contract research for its lucrative return. Clinical trials also provide limited medical access to individuals who have no or inadequate health insurance because they offer "free" doctors' visits, diagnostic tests, and medications to participants. Focusing on the professional roles of those involved, as well as key research practices, Fisher assesses the risks and advantages for physicians and patients alike when pharmaceutical drug studies are used as an alternative to standard medical care. A volume in the Critical Issues in Health and Medicine series, edited by Rima D. Apple and Janet Golden
Bibliography:Includes bibliographical references (p. 221-244) and index
ISBN:0813545935
9780813545936
0813544092
9780813544090
0813544106
9780813544106
DOI:10.36019/9780813545936